MEDICARE PART D
 9 Months Ended
Sep. 30, 2016
Insurance [Abstract]  
MEDICARE PART D
MEDICARE PART D
We cover prescription drug benefits in accordance with Medicare Part D under multiple contracts with the Centers for Medicare and Medicaid Services, or CMS, as described further in Note 2 to the consolidated financial statements included in our 2015 Form 10-K. The accompanying condensed consolidated balance sheets include the following amounts associated with Medicare Part D at September 30, 2016 and December 31, 2015. CMS subsidies/discounts in the table below include the reinsurance and low-income cost subsidies funded by CMS for which we assume no risk as well as brand name prescription drug discounts for Part D plan participants in the coverage gap funded by CMS and pharmaceutical manufacturers. The risk corridor settlement includes amounts classified as long-term because settlement associated with the 2016 provision is expected to exceed 12 months at September 30, 2016.
 
September 30, 2016
 
December 31, 2015
Risk
Corridor
Settlement
 
CMS
Subsidies/
Discounts
 
Risk
Corridor
Settlement
 
CMS
Subsidies/
Discounts
 
(in millions)
Other current assets
$
41

 
$
2,287

 
$
25

 
$
2,082

Trade accounts payable and accrued expenses
(43
)
 
(672
)
 
(47
)
 
(63
)
Net current (liability) asset
(2
)
 
1,615

 
(22
)
 
2,019

Other long-term assets
6

 
—

 
—

 
—

Other long-term liabilities
(40
)
 
—

 
—

 
—

Net long-term liability
(34
)
 
—

 
—

 
—

Total net (liability) asset
$
(36
)
 
$
1,615

 
$
(22
)
 
$
2,019


On November 1, 2016, we collected approximately $2.0 billion upon settlement with CMS for the 2015 plan year, primarily related to reinsurance and low-income cost subsidies.